Abstract
BackgroundDespite the promising therapeutic effects of adoptive transfer of tumor-infiltrating lymphocytes (TILs) in treating solid tumors, the beneficiary indication and population remains limited. Targeted selection and expansion of tumor-specific T...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have